These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 24117205)

  • 1. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
    Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
    Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans.
    Landriscina M; Pannone G; Piscazzi A; Toti P; Fabiano A; Tortorella S; Occhini R; Ambrosi A; Bufo P; Cignarelli M
    Thyroid; 2011 Nov; 21(11):1227-34. PubMed ID: 22007939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
    Saltman B; Singh B; Hedvat CV; Wreesmann VB; Ghossein R
    Surgery; 2006 Dec; 140(6):899-905; discussion 905-6. PubMed ID: 17188136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
    Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance.
    Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D
    Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression.
    Preto A; Reis-Filho JS; Ricardo S; Soares P
    Pathol Res Pract; 2002; 198(7):449-54. PubMed ID: 12234063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
    Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
    Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma.
    Chen Z; Liu N; Zhu G; Dralle H; Hoang-Vu C
    Int J Mol Med; 2012 Sep; 30(3):465-72. PubMed ID: 22751750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
    Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
    Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
    Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf-1 kinase inhibitory protein expression in thyroid carcinomas.
    Kim HS; Kim GY; Lim SJ; Kim YW
    Endocr Pathol; 2010 Dec; 21(4):253-7. PubMed ID: 20734161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatocyte nuclear factor-1alpha mRNA in human anaplastic thyroid cancer cell lines and tumors.
    Xu J; Filetti S; Hershman JM
    Thyroid; 2008 May; 18(5):533-9. PubMed ID: 18399756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.
    Buehler D; Hardin H; Shan W; Montemayor-Garcia C; Rush PS; Asioli S; Chen H; Lloyd RV
    Mod Pathol; 2013 Jan; 26(1):54-61. PubMed ID: 22899291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.
    Miettinen M; Franssila KO
    Hum Pathol; 2000 Sep; 31(9):1139-45. PubMed ID: 11014583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
    Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
    Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.